XYLD dividend yield: 9.02%. ABBV dividend yield: 3.67%. XYLD sells covered calls on the S&P 500, converting equity volatility into monthly income. Yields 8-10% depending on market conditions. Similar to QYLD but with S&P 500 exposure — less volatile but comparable income mechanics. Popular for retirement income portfolios alongside other dividend ETFs. AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.
XYLD sells covered calls on the S&P 500, converting equity volatility into monthly income. Yields 8-10% depending on market conditions. Similar to QYLD but with S&P 500 exposure — less volatile but comparable income mechanics. Popular for retirement income portfolios alongside other dividend ETFs.
AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.
Is XYLD or ABBV better for dividend income in 2026?
XYLD currently offers a 9.02% yield (3.48/share/year) while ABBV offers 3.67% (6.20/share/year). XYLD provides higher current income. However, ABBV has grown its dividend faster (8.9% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in XYLD vs ABBV earn per year?
With $10,000 invested today: XYLD pays approximately $902/year. ABBV pays approximately $367/year. With DRIP reinvestment over 10 years, these grow to $2,364/year (XYLD) and $1,154/year (ABBV).
Does XYLD or ABBV pay monthly dividends?
XYLD pays monthly dividends. ABBV pays quarterly dividends. XYLD pays monthly, which is preferred by investors who need regular cash flow.
📬
Get this XYLD vs ABBV comparison by email
Save your analysis + get weekly dividend insights. Free forever.